Next Article in Journal
Extracellular Vesicles and Their Potential Significance in the Pathogenesis and Treatment of Osteoarthritis
Next Article in Special Issue
Choroidal Volume Evaluation after Photodynamic Therapy Using New Optical Coherence Tomography Imaging Algorithm
Previous Article in Journal
Evaluation of the Effectiveness of Post-Stroke Metformin Treatment Using Permanent Middle Cerebral Artery Occlusion in Rats
Previous Article in Special Issue
Clinical Factors Associated with Low-Contrast Visual Acuity after Reduced-Fluence Photodynamic Therapy in Patients with Resolved Central Serous Chorioretinopathy and Good Baseline Visual Acuity
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 14
Issue 4
10.3390/ph14040314
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

MicroRNA-100 Mediates Hydrogen Peroxide-Induced Apoptosis of Human Retinal Pigment Epithelium ARPE-19 Cells

by
Yuh-Shin Chang
1,2,†,
Yo-Chen Chang
3,4,5,6,†,
Po-Han Chen
7,
Chia-Yang Li
3,
Wen-Chuan Wu
8,* and
Ying-Hsien Kao
7,*
1
Chi Mei Medical Center, Department of Ophthalmology, Tainan 71004, Taiwan
2
Graduate Institute of Medical Science, College of Health Science, Chang Jung Christian University, Tainan 71101, Taiwan
3
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
4
Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
5
Department of Ophthalmology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung 80145, Taiwan
6
Department of Ophthalmology, School of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
7
Department of Medical Research, E-Da Hospital, Kaohsiung 82445, Taiwan
8
Department of Ophthalmology, China Medical University Hospital, Taichung 40402, Taiwan
*
Authors to whom correspondence should be addressed.
†
These authors contribute equally to this article.
Pharmaceuticals 2021, 14(4), 314; https://doi.org/10.3390/ph14040314
Submission received: 29 October 2020 / Revised: 19 March 2021 / Accepted: 25 March 2021 / Published: 1 April 2021
(This article belongs to the Special Issue Pharmacotherapy for Macular Diseases)
Browse Figures
Review Reports Versions Notes

Abstract

:
This study investigated the regulatory role of microRNA 100 (miR-100) in hydrogen peroxide (H2O2)-induced apoptosis of human retinal pigment epithelial ARPE-19 cells. H2O2 induced oxidative cell death of cultured ARPE-19 cells was measured by cytotoxicity assay. qRT-PCR was used to quantify cytosolic and extracellular contents of miR-100. Kinase and miR-100 inhibition treatments were applied to determine the regulatory signaling pathways involved in cell death regulation. H2O2 dose-dependently reduced viability of ARPE-19 cells and simultaneously upregulated miR-100 levels in both cytosolic and extracellular compartments. Western blotting detection indicated that H2O2 elicited hyperphosphorylation of PI3K/Akt, ERK1/2, JNK, p38 MAPK, and p65 NF-κB. Further kinase inhibition experiments demonstrated that PI3K, p38 MAPK, and NF-κB activities were involved in oxidative-stress-induced miR-100 upregulation in ARPE-19 cells, while blockade of PI3K, JNK, and NF-κB signaling significantly attenuated the oxidative cell death. Intriguingly, MiR-100 antagomir treatment exerted a cytoprotective effect against the H2O2-induced oxidative cell death through attenuating the oxidation-induced AMPK hyperphosphorylation, restoring cellular mTOR and p62/SQSTM1 levels and upregulating heme oxygenase-1 expression. These findings support that miR-100 at least in part mediates H2O2-induced cell death of ARPE-19 cells and can be regarded as a preventive and therapeutic target for retinal degenerative disease.

Graphical Abstract

1. Introduction

Age-related macular degeneration (AMD) is the most common cause of blindness among patients aged 65 years and older in the Western world [1], and incidence continues to rise due to the increasing percentage of older adults in the common population. In Asia, the prevalence of late AMD is estimated to be between 0.20 and 1.90%, based on data from China [2], Japan [3], Taiwan [4], and Singapore [5]. Pathologically, AMD results from retinal pigment epithelium (RPE) dysfunction or loss associated with photoreceptor fallout, Bruch’s membrane thickening, and choriocapillary hypoperfusion [6]. The RPE is a monolayer of pigmented cells forming part of the blood retina barrier and is particularly susceptible to oxidative stress due to the layer’s high consumption of oxygen. Etiology study findings indicate that AMD is a multifactorial late-onset disease, while oxidative-stress-induced RPE cell damage is suggested to be a critical factor [7,8,9,10,11,12,13]. Antioxidant supplementation is therefore believed to be a therapeutic strategy for AMD treatment through modulating redox status balance [7,9,10,11,14].
MicroRNAs (miRNAs) are a group of noncoding RNAs with 18~22 nucleotides in length that inhibit endogenous gene expression through cleavage of gene transcript through translational cleavage [15]. In both animal and human visual systems, miRNAs have been demonstrated to be involved in various aspects of retina development, including retinogenesis, retinal homeostasis, and retinal degeneration [16,17,18]. An increasing body of evidence also identifies miRNA signatures in vitreous humors and plasma of AMD patients and suggests that some candidate miRNAs are plausible therapeutic targets for gene therapy [19,20,21,22]. MiRNA-100 (miR-100) belongs to the miR-99 family, whose members include miR-99a, miR-99b, and miR-100, and has long been known as a key apoptotic regulator in various cell types, mostly in cancer cells [23,24,25,26,27,28,29,30]. Previous studies on cardiovascular system have suggested that elevated miR-100 is involved in heart failure [31], while miR-100 gene silencing protects oxidative-stress-induced apoptosis of cultured neonatal cardiomyocytes [32]. These findings support that miR-100 plays an important role in the regulation of oxidative-related necroptosis of ischemic cells. In the retina, hydrogen peroxide (H2O2)-induced oxidative stress has been demonstrated to specifically up-regulate miR-100 expression in cultured rat retinal ganglion RGC-5 cells undergoing apoptotic cell death, while miR-100 depletion exerts anti-apoptosis effect through insulin-like growth factor 1 receptor (IGF1R) and Akt/ERK/Trkβ pathways in the retinal ganglion cells [33]. MiR-100 is also found to be constitutively expressed in retinal microvascular endothelial cells, but its expression is suppressed by angiogenic stimulation during ocular angiogenesis [34]. Despite lacking clinical evidence, those findings strongly suggest that miR-100 is widely distributed in retinal tissues and contributes to ocular disorders. To date, the regulatory role of oxidative stress in miR-100 biosynthesis in RPE cells remains elusive. Despite lacking clinical evidence, we hypothesized that the oxidation-induced miR-100 upregulation in RPE cells is very likely involved in the pathogenesis of AMD. To test our hypothesis, this study aimed at characterizing whether H2O2-mimicked oxidative stress also induces ARPE-19 cell apoptosis via upregulating miR-100 biogenesis and its release, examining the signal pathways involved in the miR-100 upregulation, determining the cytoprotective effect of miR-100 antagomir treatment against oxidative cell death, and the possible underlying mechanism.

2. Results

2.1. Oxidative Stress Increased miR-100 Biosynthesis in Human ARPE-19 Cells

Recent studies have evidenced that the existence of miRNA in the extracellular vesicles released by RPE cells may contribute to retinal pathophysiolgical processes [35,36]. To characterize the profiles of miR-100 biosynthesis and its release in response to oxidative stress, we first examined the cytotoxic effect of H2O2-mimicked oxidative stress in human ARPE-19 RPE cells by exposing cells to various concentrations of H2O2, and consequent cell viability was determined by MTT cytotoxicity assay. The results showed that 24-h persistent H2O2 exposure significantly reduced viability of ARPE-19 cells at doses higher than 125 μM and induced dose-dependent cytotoxicity (Figure 1A). Meanwhile, both cytosolic and released levels of miR-100 in response to H2O2 treatment were profiled by reverse transcription and quantitative real-time PCR (RT-qPCR) detection. The results indicated that both cytosolic and released contents of miR-100 significantly increased in a dose-dependent manner by oxidative stress (Figure 1B,C). This evidence substantially links the miR-100 upregulation with oxidative cell death of ARPE-19 cells.

2.2. Signaling Profiles of Oxidative Stress-Driven Cytotoxicity of ARPE-19 Cells

Since a broad spectrum of signal pathways including PI3K/Akt, MAPK, and NF-κB are involved in the pro-inflammatory and pro-survival responses in RPE cells against oxidative stress [37,38,39,40,41], we next scrutinized the signaling profiles in H2O2-treated ARPE-19 cells by measuring total and phosphorylated levels of signaling mediators (Figure 2A). Western blotting and densitometrical analysis indicated that H2O2 treatment prominently elicited instant hyperphosphorylation of Akt, ERK1/2, JNK, and p38 MAPK (Figure 2B–E), peaking within 1 h after the addition of H2O2. By contrast, H2O2 induced NF-κB hyperphosphorylation occurred at around 3 to 6 h after addition (Figure 2F). These data confirmed the responsiveness of these signaling pathways to the oxidative-stress-induced toxicity of ARPE-19 cells.

2.3. Signal Pathways Involved in Oxidative-Stress-Induced miR-100 Biosynthesis and Cytotoxicity in ARPE-19 Cells

To determine which signal pathway is involved in the oxidative-stress-induced miR-100 biosynthesis in RPE cells, ARPE-19 cells were pretreated with different selective kinase inhibitors and exposed to H2O2 addition, followed by RT-qPCR detection for miR-100 levels in lysates and condition media. Detection results clearly showed that inhibition of PI3K and p38 MAPK activities partially attenuated H2O2-upregulated cytosolic miR-100 contents, while NF-κB signal blockade completely suppressed this upregulation (Figure 3A). Similar trends were noted in miR-100 levels of conditioned media in that PI3K/Akt and p38 inhibition abolished H2O2-increased miR-100 release from ARPE-19 cells (Figure 3B). Intriguingly, NF-κB signal blockade did not affect the increased release of miR-100, whereas JNK inhibition conversely potentiated the H2O2-induced miR-100 release.
To further examine the involvement of signaling pathways in the oxidative-stress-induced RPE cytotoxicity, APRE-19 cells were again pretreated with kinase inhibitors and received H2O2 exposure, followed by cytotoxicity assay. Cell viability data indicated that the abolishment of Akt, JNK, and NF-κB signaling activation did not affect persistent H2O2 exposure-induced cytotoxicity (data not shown), but significantly ameliorated transient H2O2 treatment-induced cytotoxicity in ARPE-19 cells (Figure 4). Taken with the above miR-100 changes in the treated cells, these findings suggest that both PI3K/Akt and NF-κB signal axes are involved in the oxidative stress-elicited miR-100 changes and cell death of RPE cells.

2.4. Suppressive Effect of miR-100 Antagomir on Oxidative Cell Death in ARPE-19 Cells

Given the positive role of miR-100 in oxidative cell death, we next determined whether miR-100 antagonism protects RPE cells against oxidative stress injury. To this end, ARPE-19 cells were transfected with miR-100 antagomir or non-specific miRNA oligonucleotides for 24 h, followed by another 24-h H2O2 exposure. RT-qPCR measurement confirmed that H2O2 exposure markedly increased miR-100 levels in both cytosol and conditioned media, while miR-100 levels were not detectable in both compartments after miR-100 antagonistic transfection (Figure 5A). Meanwhile, cytotoxicity assay data demonstrated that miR-100 antagonism significantly reduced the H2O2-induced cell death in ARPE-19 cells (Figure 5B). In addition, the result of a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay supported that miR-100 antagonism effectively alleviated oxidation-related apoptotic death of ARPE-19 cells (Figure 5C,D). These findings strongly suggest that miR-100 is a novel target for preventing oxidative RPE cell death.

2.5. Effects of miR-100 Antagomir on AMPK/mTOR and Antioxidant Expression in ARPE-19 Cells

Given that the AMPK-dependent upregulation of heme oxygenase-1 (HO-1) antioxidant expression protects ARPE-19 cells against oxidative-stress-induced apoptosis [42], we next examined whether AMPK/mTOR axis and HO-1 expression are involved in the miR-100 antagomir exhibited cytoprotection against oxidative injury of RPE cells. Protein lysates collected from the cells receiving an miR-100 antagonist or control miRNA and subsequent H2O2 exposure were subjected to western blotting detection (Figure 6A). The blotting and densitometry data clearly showed that H2O2 exposure prominently induced AMPK hyperphosphorylation, while miR-100 antagonistic treatment completely abolished this induction (Figure 6B). By contrast, H2O2 treatment reduced total protein levels of mTOR, while miR-100 antagomir intriguingly reversed this reduction (Figure 6C), despite no apparent effect on mTOR phosphorylation levels (data not shown). Moreover, the miR-100 antagomir significantly elevated constitutive HO-1 expression and augmented the H2O2-induced HO-1 upregulation in ARPE-19 cells (Figure 6D), strongly suggesting activation of the Nrf-2 signal in the cells receiving the antagomir treatment under oxidative stress condition. Given that p62 sequestosome 1 (p62/SQSTM1) is reported to protect RPE cells against the oxidative stress associated with cell death via activating the Nrf2/HO-1 axis [43,44], the miR-100 antagomir treatment dramatically restored cellular p62 expression in the cells under oxidative stress (Figure 6E). Immunofluorescent staining also demonstrated that the increased p62 peptides were mainly distributed in perinuclear subcellular locations in the treated cells (Figure 7). Taken together, these findings suggested that not only restoration of cellularAMPK/mTOR levels but also activation of p62/Nrf-2/HO-1 signal axis are involved in the cytoprotective effect of miR-100 inhibition against the oxidative injury in RPE cells.

3. Discussion

The pro-apoptotic role of miR-100 has been previously demonstrated in many diseases, in particular extensively discussed in the regulation of tumorigenesis. However, the expression and function of miR-100 vary among different cell types in the tumors. Earlier clinical observatory studies report that miR-100 expression is downregulated in cancer cells, while this miR-100 downregulation enhances tumorigenesis. In the mechanistic context, miR-100 functionally suppresses proliferation and motility [25], induces apoptosis, and enhances the chemosensitivity of cancer cells [26,27]. Conversely, an in vivo miRNA study identifies that loss of miR-100 function in tumor cells enhances clonogenic survival and results in the reduction of apoptosis and radiosensitivity [28]. By contrast, it is reported that abundant expression of miR-100 in exosomes secreted from prostate cancer stimulates matrix metalloproteinase expression, thereby contributing to the pro-metastatic niche during tumor development [45]. Moreover, the highly expressed miR-100 maintains the phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis in mice, while intratumoral injection with an miR-100 inhibitor and combined cisplatin therapy showed better benefits for breast cancer therapy [29]. These findings strongly suggest that, under pathogenetic and oxidative conditions, the vitreous and endogenous miR-100 levels may play an essential role in determining the cell fate of resident retinal cells including the RPE cells. In this regard, more clinical and preclinical studies may further warrant the pathogenetic role of miR-100 in AMD.
Recent advances have emphasized the importance of oxidative stress in the pathogenesis of AMD, thus numerous novel therapeutics were designed to alleviate apoptotic cell death of RPE by supplementing antioxidant or raising antioxidant expression in retinal tissues. Despite the fact that miRNA dysregulation is a common event in human diseases including cancers and ocular diseases, the present study demonstrated that biosynthesis and release of miR-100 increased in cultured RPE cells under oxidative stress, thereby regulating cellular apoptosis. Our findings not only support the involvement of miR-100 elevation in the pathogenesis of AMD and unravel the signaling mechanisms governing miR-100 biosynthesis, but also clarify the anti-apoptotic effect of miR-100 antagomir treatment in cultured RPE cells. Collectively, miR-100 is strongly suggested as a potential therapeutic target in the prevention of oxidative RPE cell death and AMD treatment.
The findings of this study delineate the signal network elicited by H2O2-reduced oxidative stress and its possible connection to endogenous miR-100 biosynthesis and consequent apoptotic cell death of RPE cells (Figure 8). The findings of kinase inhibition experiments determining how the miR-100 expression and release is regulated within the cells suggest the involvement of PI3K/Akt, p38 MAPK, and NF-κB pathways in its biosynthesis, while Akt and p38 signal activities participate in the regulation of its release from the cells. Due to the concern for the potential non-specificity of kinase inhibitors, further study by using genetic intervention tools may warrant the validity of this result. Since p38 MAPK reportedly mediates adenosine-induced alterations in myocardial glucose utilization via AMPK, which is thus claimed to likely lie downstream of p38 MAPK, p38 inhibition restores adenosine-induced cardioprotection in the stressed hearts [46]. However, the present study demonstrated that p38 inhibition alleviated H2O2-increased miR-100 biosynthesis in, and its release from, ARPE-19 cells but contradictorily did not protect them from oxidative cell death. In contrast, inhibition of Akt, JNK, and NF-κB signaling activities significantly reversed the H2O2-reduced cell viability, implicating that miR-100 biosynthesis is not the sole player in cell fate determination. Among these pathways, blockade of the NF-κB signal axis might be the most potent player that suppresses the oxidative-stress-induced miR-100 biosynthesis and subsequent RPE cell death. Moreover, the delayed phosphorylation in response to H2O2 exposure implicates that the NF-κB signal mediator likely lies downstream of the Akt and JNK axes and converges both signaling activities, so that its signal blockade elicits a better cytoprotective effect. However, the discrepancy between the miR-100 biosynthesis and cell viability upon JNK inhibition under oxidative stress has not been resolved to date [47] and more studies may warrant further elucidation.
In the mechanistic context of oxidative retinal injury, H2O2 is widely known to activate AMPK and inhibit mTOR activation in ARPE-19 cells [38,39,40]. Given that AMPK is an upstream negative regulator of mTOR [48], the PI3K/Akt and mTOR axes are known to mediate RPE cell survival during oxidative-stress-induced apoptosis [37]. In this regard, the α-melanocyte-stimulating hormone is reported to trigger Akt/mTOR pro-survival signaling in the RPE cells under oxidative stress [39], while the rapamycin-sensitive mTOR activation is found to mediate nerve growth factor-induced cell migration and pro-survival signals against oxidative stress in RPE cells [40]. In fact, the tumor-suppressive effect of miR-100 has long been recognized to lie in its targeting effect on mTOR expression in tumor cells, thereby modulating chemo- and radio-sensitivities [27]. miR-100 additionally inhibits IGF-1R expression not only in hepatocellular carcinoma cells [30] but also in retinal ganglion cells [33], highlighting the significance of miR-100 in regulating the IGF-1R/Akt-mediated pro-survival signals and implicating its clinical applicability in preventing retinal ganglion cell death.
More importantly, this study uncovers the relationship between miR-100 and HO-1 antioxidant expression in RPE cells. Consistent with the protective role of mTOR complex 1 signaling activation and subsequent Nrf2/HO-1 axis against oxidative-stress-induced RPE cell death [42], this study presents the first evidence that miR-100 antagomir treatment concurrently attenuates oxidative stress-related AMPK phosphorylation, restores cellular mTOR and p62 levels, and upregulates HO-1 expression in ARPE-19 cells. The elevation of p62 expression under oxidative stress is found to disrupt inhibitory interaction between Nrf2 and Keap1 proteins, thereby leading to increased expression of Nrf2 target genes and consequent antioxidant response [43,44]. In addition to the regulatory role of the Nrf2/HO-1 axis in RPE cells, the p62 sequestosome protein also recognizes ubiquitinated perinuclear aggregates and the p62-tagged materials can be eradicated from cytosol [49]. Therefore, the dual cytoprotective mechanisms of p62 restoration through the activation of Nrf2 signaling and autophagy clearance of misfolded proteins have been claimed to be a potential target for preventing oxidative cell death of RPE and treating AMD [43]. While the role of p62 expression has been linked with autophagy function, scavenger receptor expression, and phagocytosis [50,51], the effect of miR-100 antagomir treatment on autophagic and phagocytic functions of RPE deserves further elucidation. Moreover, a negative correlation between miR-100 and p62 expression is significantly noted in hepatocellular carcinoma cells [30], supporting their reciprocal regulation in the cells. Taken together, the restoration of cellularAMPK/mTOR levels and the activation of p62/Nrf-2/HO-1 signal axis miR-100 antagonistic agents strongly support the therapeutic applicability in the AMD.
The pro-angiogenic role of miR-100 previously reported in tumor formation may provide mechanistic insights on the regulatory relationship between miR-100 and signaling activity in the RPE cells. In this context, miR-100 enrichment in mesenchymal stem cell-derived exosomes has been found to mediate VEGF expression in breast cancer cells [52]. In the context of ocular angiogenesis, miR-100 is constitutively and highly expressed in retinal microvascular endothelial cells, but its expression is suppressed by angiogenic stimulation [34], suggesting differential roles of miR-100 in promoting tumoral angiogenesis but suppressing retinal neovascularization. Nevertheless, the involvement of miR-100 in repressing mTOR signaling has been previously identified in endothelial and vascular smooth muscle cells [53], consistently supporting its anti-angiogenic role as well as its suppressive effect on mTOR signaling in ARPE-19 cells. Moreover, an animal study by using streptozotocin-induced diabetic retinopathy corroborates that upregulation of NF-κB- and VEGF-responsive miRNAs in the retina and retinal endothelial cells constitute a key miRNA signature that contributes to pathologic changes of early diabetic retinopathy [54], implicating a negative feedback regulation of NF-κB activation during ocular neovascularization. Furthermore, our findings clearly showed that NF-κB signaling inhibition completely suppressed H2O2-induced miR-100 biosynthesis in ARPE-19 cells, suggesting that miR-100 very likely plays distinct roles in the pathogeneses of dry and wet AMD. However, clinical comparative study on miR-100 profiles in both types of AMD may warrant further elucidation. In conclusion, this study demonstrated that miR-100 mediates oxidative cell death of ARPE-19 cells and the downregulation of miR-100 via antagonistic agents may constitute a therapeutic strategy for the treatment of AMD.

4. Materials and Methods

4.1. Reagents

Selective kinase-specific inhibitors including LY294002 for PI3K, SB203580 for p38 MAPK, PD98059 for MAPK/ERK kinase 1 (MEK1), SP600125 for JNK, and PDTC for NF-κB inhibition were purchased from Sigma-Aldrich (St. Louis, MO, USA). All inhibitors were dissolved in DMSO and stocked at 10 mM at −20 °C. Antibodies raised against phospho-Akt (Ser 473), phospho-ERK1/2 (Thr202/185 and Tyr204/187), phospho-p38 MAPK (Thr180/Tyr182), phospho-JNK (Thr183/Tyr185), phospho-NF-κB (Ser536), phospho-AMPKα1 (Thr172), phospho-mTOR (Ser2448), and those against respective total proteins were purchased from Cell Signaling (Beverly, MA, USA). Antibody against HO-1 was purchased from Enzo Life Sciences Inc. (Farmingdale, NY, USA) and that against β-Actin was from Merck Millipore (Temecula, CA, USA).

4.2. Cell Culture and Treatment

A human RPE cell line, ARPE-19, was obtained from American Type Culture Collection (Manassas, VA, USA) and cultured in a Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 1:1 nutrient mixture medium supplemented with 10% fetal bovine serum and regular antibiotics (Invitrogen/Gibco, Gaithersburg, MD, USA) in a humidified atmosphere containing 5% CO2 at 37 °C. The cells were previously authenticated by short tandem repeat DNA profiling analysis (Supplementary Figure S1) and used for study within three passages after thawing. To mimic oxidative stress, ARPE-19 cells were treated with H2O2 dissolved in a medium at the indicated dose for either persistent 24-h or transient 2-h periods, the cellular lysates and supernatants were collected and subjected to detection assays as described below.

4.3. Cytotoxicity Assay

A 3-(4, 5-dimethylthiozol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) (Sigma- Aldrich, St. Louis, MO, USA) based cell proliferation assay was used to measure the cytotoxic effect of oxidative on ARPE-19 cells as previously described [55]. In brief, ARPE-19 cells were plated in 96 well plates at a density of 2 × 105 cells/cm2. At the end of MTT (500 μg/mL) incubation, optical density was measured at 540 nm by a microplate reader (Sunrise™, Tecan, Mannedorf, Switzerland). All groups were tested in triplicate and the cells without chemical treatment were used as negative controls and the wells without cells as blank controls.

4.4. MiRNA Semi-Quantification

miRNA was extracted from cell lysates and conditioned media by using a High Pure miRNA Isolation Kit (Roche Applied Science, Mannheim, Germany) according to the manufacturer’s instructions. The collected supernatants were centrifuged to remove floating cells and debris prior to detection. Subsequent RT-qPCR was performed by a TaqMan Advanced miRNA Assay Kit (Thermo Fisher Scientific Inc., Waltham, MA, USA) using an Eco Real-Time PCR System (Illumina, San Diego, CA, USA) according to the manufacturer’s instructions. Cellular miR-361 level in H2O2-treated cells was verified stable and used as internal controls. Expression levels of miR-100 were normalized to the endogenous miR-361 level and presented as folder changes (2-ΔΔCt) against the negative control. A medium-alone control was used to exclude the pre-existence of miR-100 in the culture medium.

4.5. Western Blotting

After drug treatment, ARPE-19 cells were rinsed with ice-cold PBS and lyzed in prechilled RIPA buffer with the addition of protease and phosphatase inhibitors. After protein quantification, 50 µg of total cell lysates were electrophoresed, electrotransferred, and immunodetected using the previously described protocol [56]. The immunoreactive signals were documented with the enhanced chemiluminescence detection system (Millipore, Temecula, CA, USA). Band density was measured using ImageJ image analytical software (National Institutes of Health, Bethesda, MD, USA). The relative expression levels of target proteins are shown by the density ratio to β-Actin internal control or to unphosphorylated total protein in the same sample. All density results were obtained from three independent experiments and normalized as percentage or induction folds of negative control level.

4.6. TUNEL Staining

ARPE-19 cells were fixed with ice-cold paraformaldehyde after receiving treatment and subjected to a TUNEL-based in situ cell death detection assay. Fluorescent TUNEL assay was performed according to the standard protocol provided by the manufacturer (Roche, Mannheim, Germany). After staining, a mounting medium containing DAPI was used to identify nuclei of cells. Quantification of fluorescent positive signals in each group was performed by counting at least 10 randomly selected images at high-power fields under fluorescent microscopy and the TUNEL positivity was shown in the percentage of total cells.

4.7. Transfection of miR-100 Inhibitor

Single-stranded and RNA-based oligonucleotides specifically targeting hsa-miR-100-5p (miR-100 inhibitor) were synthesized by Ambion (Thermo Fisher Scientific Inc., Waltham, MA, USA). ARPE-19 cells were transfected with a 200 nM miR-100 inhibitor by using Lipofectamine 2000 24 h before H2O2 treatment. In control experiments, cells were transfected with 200 nM non-specific control miRNA.

4.8. Immunofluorescent Staining

ARPE-19 cells, after treatments, were fixed with ice-cold methanol and permeabilized with PBS containing 0.2% Triton X-100. The cells were then blocked with 1% BSA and stained with 2 μg/mL anti-p62/SQSTM1 antibody (Santa Cruz Biotechnology, CA, USA) for overnight incubation at 4 °C, followed by treatment with Alexa488-conjugated anti-mouse IgG for 1 h at room temperature in the dark. After washes, the cells were counterstained with 1 μg/mL DAPI for 10 min, mounted with DAKO fluorescent mounting fluid, and observed under a fluorescent microscope (Axiovert, Zeiss, Germany).

4.9. Statistical Analysis

All results are expressed as the mean ± SD. Data were analyzed by using an unpaired Student’s t-test with two-tailed analysis or one-way ANOVA followed by Tukey’s post hoc test. p-values < 0.05 are considered statistically significant.

5. Conclusions

In conclusion, this study demonstrated that the H2O2 -mimicked oxidative stress in cultured ARPE-19 cells may trigger miR-100 biosynthesis that mediates apoptotic cell death, while the signal pathways including PI3K/Akt, p38 MAPK, and NF-κB were involved in oxidative-stress-induced miR-100 upregulation in the cells. Conversely, miR-100 antagomir treatment exerted a cytoprotective effect against the H2O2-induced oxidative cell death through attenuating the oxidation-induced AMPK hyperphosphorylation, restoring cellular mTOR and p62 levels and upregulating heme oxygenase-1 expression. Our findings strongly support that miR-100 antagonism can be regarded as a preventive/therapeutic strategy for treatment of retinal degenerative disease.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/ph14040314/s1, Figure S1: Short tandem repeat (STR) genotyping analysis on AR-PE-19 cell line used in the study.

Author Contributions

Authorship must be limited to those who have contributed substantially to the work reported. Conceptualization, W.-C.W. and Y.-H.K.; methodology, P.-H.C. and C.-Y.L.; investigation, Y.-S.C.; resources, C.-Y.L.; writing—original draft preparation, Y.-S.C. and Y.-C.C.; writing—review and editing, W.-C.W. and Y.-H.K.; visualization, Y.-C.C.; supervision, Y.-H.K.; funding acquisition, Y.-S.C., Y.-C.C. and Y.-H.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Ministry of Science and Technology, Executive Yuan, grant number MOST107-2314-B-384-009, Chi Mei Medical Center grant number CMMOST10721, Kaohsiung Medical University Hospital grant number 107-7R48, 5T02, Kaohsiung Municipal Ta-Tung Hospital grant number 108-R02, and E-Da Hospital grant number EDAHT107039.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Friedman, D.S.; O’Colmain, B.J.; Munoz, B.; Tomany, S.C.; McCarty, C.; de Jong, P.T.; Nemesure, B.; Mitchell, P.; Kempen, J. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004, 122, 564–572. [Google Scholar] [PubMed] [Green Version]
  2. Yang, K.; Liang, Y.B.; Gao, L.Q.; Peng, Y.; Shen, R.; Duan, X.R.; Friedman, D.S.; Sun, L.P.; Mitchell, P.; Wang, N.L.; et al. Prevalence of age-related macular degeneration in a rural Chinese population: The Handan Eye Study. Ophthalmology 2011, 118, 1395–1401. [Google Scholar] [CrossRef] [PubMed]
  3. Kawasaki, R.; Wang, J.J.; Ji, G.J.; Taylor, B.; Oizumi, T.; Daimon, M.; Kato, T.; Kawata, S.; Kayama, T.; Tano, Y.; et al. Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: The Funagata study. Ophthalmology 2008, 115, 1376–1381. [Google Scholar] [CrossRef]
  4. Chen, S.J.; Cheng, C.Y.; Peng, K.L.; Li, A.F.; Hsu, W.M.; Liu, J.H.; Chou, P. Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: The Shihpai Eye Study. Investig. Ophthalmol. Vis. Sci. 2008, 49, 3126–3133. [Google Scholar] [CrossRef] [PubMed]
  5. Kawasaki, R.; Wang, J.J.; Aung, T.; Tan, D.T.; Mitchell, P.; Sandar, M.; Saw, S.M.; Wong, T.Y. Prevalence of age-related macular degeneration in a Malay population: The Singapore Malay Eye Study. Ophthalmology 2008, 115, 1735–1741. [Google Scholar] [CrossRef] [PubMed]
  6. Feigl, B. Age-related maculopathy—Linking aetiology and pathophysiological changes to the ischaemia hypothesis. Prog. Retin. Eye Res. 2009, 28, 63–86. [Google Scholar] [CrossRef] [PubMed]
  7. Van Lookeren Campagne, M.; LeCouter, J.; Yaspan, B.L.; Ye, W. Mechanisms of age-related macular degeneration and therapeutic opportunities. J. Pathol. 2014, 232, 151–164. [Google Scholar] [CrossRef] [PubMed]
  8. Campochiaro, P.A. The pathogenesis of age-related macular degeneration. Mol. Vis. 1999, 5, 24. [Google Scholar]
  9. Algvere, P.V.; Seregard, S. Age-related maculopathy: Pathogenetic features and new treatment modalities. Acta Ophthalmol. Scand. 2002, 80, 136–143. [Google Scholar] [CrossRef]
  10. Beatty, S.; Koh, H.; Phil, M.; Henson, D.; Boulton, M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000, 45, 115–134. [Google Scholar] [CrossRef] [Green Version]
  11. Khandhadia, S.; Lotery, A. Oxidation and age-related macular degeneration: Insights from molecular biology. Expert Rev. Mol. Med. 2010, 12, e34. [Google Scholar] [CrossRef] [PubMed]
  12. Hollyfield, J.G.; Bonilha, V.L.; Rayborn, M.E.; Yang, X.; Shadrach, K.G.; Lu, L.; Ufret, R.L.; Salomon, R.G.; Perez, V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 2008, 14, 194–198. [Google Scholar] [CrossRef] [PubMed]
  13. Zarbin, M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol. 2004, 122, 598–614. [Google Scholar] [CrossRef] [Green Version]
  14. Moriarty-Craige, S.E.; Adkison, J.; Lynn, M.; Gensler, G.; Bressler, S.; Jones, D.P.; Sternberg, P., Jr. Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration. Am. J. Ophthalmol. 2005, 140, 1020–1026. [Google Scholar] [CrossRef] [PubMed]
  15. Pillai, R.S. MicroRNA function: Multiple mechanisms for a tiny RNA? RNA 2005, 11, 1753–1761. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Loscher, C.J.; Hokamp, K.; Wilson, J.H.; Li, T.; Humphries, P.; Farrar, G.J.; Palfi, A. A common microRNA signature in mouse models of retinal degeneration. Exp. Eye Res. 2008, 87, 529–534. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Loscher, C.J.; Hokamp, K.; Kenna, P.F.; Ivens, A.C.; Humphries, P.; Palfi, A.; Farrar, G.J. Altered retinal microRNA expression profile in a mouse model of retinitis pigmentosa. Genome Biol. 2007, 8, R248. [Google Scholar] [CrossRef] [Green Version]
  18. Hackler, L., Jr.; Wan, J.; Swaroop, A.; Qian, J.; Zack, D.J. MicroRNA profile of the developing mouse retina. Investig. Ophthalmol. Vis. Sci. 2010, 51, 1823–1831. [Google Scholar] [CrossRef]
  19. Ren, C.; Liu, Q.; Wei, Q.; Cai, W.; He, M.; Du, Y.; Xu, D.; Wu, Y.; Yu, J. Circulating miRNAs as potential biomarkers of age-related macular degeneration. Cell. Physiol. Biochem. 2017, 41, 1413–1423. [Google Scholar] [CrossRef]
  20. Romano, G.L.; Platania, C.B.M.; Drago, F.; Salomone, S.; Ragusa, M.; Barbagallo, C.; Di Pietro, C.; Purrello, M.; Reibaldi, M.; Avitabile, T.; et al. Retinal and circulating miRNAs in age-related macular degeneration: An in vivo animal and human study. Front. Pharmacol. 2017, 8, 168. [Google Scholar] [CrossRef] [Green Version]
  21. Askou, A.L.; Alsing, S.; Holmgaard, A.; Bek, T.; Corydon, T.J. Dissecting microRNA dysregulation in age-related macular degeneration: New targets for eye gene therapy. Acta Ophthalmol. 2017, 96, 9–23. [Google Scholar] [CrossRef] [Green Version]
  22. Menard, C.; Rezende, F.A.; Miloudi, K.; Wilson, A.; Tetreault, N.; Hardy, P.; SanGiovanni, J.P.; De Guire, V.; Sapieha, P. MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD. Oncotarget 2016, 7, 19171–19184. [Google Scholar] [CrossRef] [Green Version]
  23. Nagaraja, A.K.; Creighton, C.J.; Yu, Z.; Zhu, H.; Gunaratne, P.H.; Reid, J.G.; Olokpa, E.; Itamochi, H.; Ueno, N.T.; Hawkins, S.M.; et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol. Endocrinol. 2010, 24, 447–463. [Google Scholar] [CrossRef] [Green Version]
  24. Shi, W.; Alajez, N.M.; Bastianutto, C.; Hui, A.B.; Mocanu, J.D.; Ito, E.; Busson, P.; Lo, K.W.; Ng, R.; Waldron, J.; et al. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int. J. Cancer 2010, 126, 2036–2048. [Google Scholar] [CrossRef]
  25. Xu, C.; Zeng, Q.; Xu, W.; Jiao, L.; Chen, Y.; Zhang, Z.; Wu, C.; Jin, T.; Pan, A.; Wei, R.; et al. miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR. Mol. Cancer Ther. 2012, 12, 207–219. [Google Scholar] [CrossRef] [Green Version]
  26. Gong, Y.; He, T.; Yang, L.; Yang, G.; Chen, Y.; Zhang, X. The role of miR-100 in regulating apoptosis of breast cancer cells. Sci. Rep. 2015, 5, 11650. [Google Scholar] [CrossRef] [Green Version]
  27. Zhang, B.; Zhao, R.; He, Y.; Fu, X.; Fu, L.; Zhu, Z.; Dong, J.T. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR. Oncotarget 2015, 7, 5702–5714. [Google Scholar] [CrossRef] [Green Version]
  28. Fahim Golestaneh, A.; Lecker, L.S.M.; Schlegel, J.; Nowrouzi, A.; Schwager, C.; Meister, S.; Weichert, W.; Debus, J.; Abdollahi, A. Large scale in vivo micro-RNA loss of function screen identified miR-29a, miR-100 and miR-155 as modulators of radioresistance and tumor-stroma communication. Int. J. Cancer 2019, 144, 2774–2781. [Google Scholar] [CrossRef] [PubMed]
  29. Wang, W.; Liu, Y.; Guo, J.; He, H.; Mi, X.; Chen, C.; Xie, J.; Wang, S.; Wu, P.; Cao, F.; et al. miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a/IL-1ra pathway in mouse breast cancer. Oncogenesis 2018, 7, 97. [Google Scholar] [CrossRef] [PubMed]
  30. Ge, Y.Y.; Shi, Q.; Zheng, Z.Y.; Gong, J.; Zeng, C.; Yang, J.; Zhuang, S.M. MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R. Oncotarget 2014, 5, 6218–6228. [Google Scholar] [CrossRef] [Green Version]
  31. Sucharov, C.; Bristow, M.R.; Port, J.D. miRNA expression in the failing human heart: Functional correlates. J. Mol. Cell. Cardiol. 2008, 45, 185–192. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Chen, A.; Li, G.; Chen, L.; Guo, J.; Liu, Y. Downregulation of microRNA-100 protects H2O2-induced apoptosis in neonatal cardiomyocytes. Int. J. Clin. Exp. Pathol. 2015, 8, 5491–5496. [Google Scholar] [PubMed]
  33. Kong, N.; Lu, X.; Li, B. Downregulation of microRNA-100 protects apoptosis and promotes neuronal growth in retinal ganglion cells. BMC Mol. Biol. 2014, 15, 25. [Google Scholar] [CrossRef] [Green Version]
  34. Walz, J.M.; Wecker, T.; Zhang, P.P.; Cakir, B.; Gruening, B.; Agostini, H.; Reuer, T.; Ludwig, F.; Boneva, S.; Faerber, L.; et al. Impact of angiogenic activation and inhibition on miRNA profiles of human retinal endothelial cells. Exp. Eye Res. 2019, 181, 98–104. [Google Scholar] [CrossRef]
  35. Morris, D.R.; Bounds, S.E.; Liu, H.; Ding, W.Q.; Chen, Y.; Liu, Y.; Cai, J. Exosomal miRNA transfer between retinal microglia and RPE. Int. J. Mol. Sci. 2020, 21, 3541. [Google Scholar] [CrossRef]
  36. Zhang, Y.; Wang, K.; Pan, J.; Yang, S.; Yao, H.; Li, M.; Li, H.; Lei, H.; Jin, H.; Wang, F. Exosomes mediate an epithelial-mesenchymal transition cascade in retinal pigment epithelial cells: Implications for proliferative vitreoretinopathy. J. Cell. Mol. Med. 2020, 24, 13324–13335. [Google Scholar] [CrossRef]
  37. Faghiri, Z.; Bazan, N.G. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis. Exp. Eye Res. 2010, 90, 718–725. [Google Scholar] [CrossRef] [Green Version]
  38. Yao, J.; Bi, H.E.; Sheng, Y.; Cheng, L.B.; Wendu, R.L.; Wang, C.H.; Cao, G.F.; Jiang, Q. Ultraviolet (UV) and hydrogen peroxide activate ceramide-ER stress-AMPK signaling axis to promote retinal pigment epithelium (RPE) cell apoptosis. Int. J. Mol. Sci. 2013, 14, 10355–10368. [Google Scholar] [CrossRef] [Green Version]
  39. Cheng, L.B.; Cheng, L.; Bi, H.E.; Zhang, Z.Q.; Yao, J.; Zhou, X.Z.; Jiang, Q. Alpha-melanocyte stimulating hormone protects retinal pigment epithelium cells from oxidative stress through activation of melanocortin 1 receptor-Akt-mTOR signaling. Biochem. Biophys. Res. Commun. 2014, 443, 447–452. [Google Scholar] [CrossRef]
  40. Cao, G.F.; Liu, Y.; Yang, W.; Wan, J.; Yao, J.; Wan, Y.; Jiang, Q. Rapamycin sensitive mTOR activation mediates nerve growth factor (NGF) induced cell migration and pro-survival effects against hydrogen peroxide in retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 2011, 414, 499–505. [Google Scholar] [CrossRef]
  41. Wu, W.C.; Hu, D.N.; Gao, H.X.; Chen, M.; Wang, D.; Rosen, R.; McCormick, S.A. Subtoxic levels hydrogen peroxide-induced production of interleukin-6 by retinal pigment epithelial cells. Mol. Vis. 2010, 16, 1864–1873. [Google Scholar] [PubMed]
  42. Zhang, H.; Liu, Y.Y.; Jiang, Q.; Li, K.R.; Zhao, Y.X.; Cao, C.; Yao, J. Salvianolic acid A protects RPE cells against oxidative stress through activation of Nrf2/HO-1 signaling. Free Radic. Biol. Med. 2014, 69, 219–228. [Google Scholar] [CrossRef] [PubMed]
  43. Wang, L.; Cano, M.; Handa, J.T. p62 provides dual cytoprotection against oxidative stress in the retinal pigment epithelium. Biochim. Biophys. Acta 2014, 1843, 1248–1258. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Kolosova, N.G.; Kozhevnikova, O.S.; Telegina, D.V.; Fursova, A.Z.; Stefanova, N.A.; Muraleva, N.A.; Venanzi, F.; Sherman, M.Y.; Kolesnikov, S.I.; Sufianov, A.A.; et al. p62/SQSTM1 coding plasmid prevents age related macular degeneration in a rat model. Aging 2018, 10, 2136–2147. [Google Scholar] [CrossRef]
  45. Sanchez, C.A.; Andahur, E.I.; Valenzuela, R.; Castellon, E.A.; Fulla, J.A.; Ramos, C.G.; Trivino, J.C. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche. Oncotarget 2016, 7, 3993–4008. [Google Scholar] [CrossRef] [Green Version]
  46. Jaswal, J.S.; Gandhi, M.; Finegan, B.A.; Dyck, J.R.; Clanachan, A.S. p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5′-AMP-activated protein kinase. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H1978–H1985. [Google Scholar] [CrossRef]
  47. Kim, B.J.; Zack, D.J. The role of c-Jun N-terminal kinase (JNK) in retinal degeneration and vision loss. Adv. Exp. Med. Biol. 2018, 1074, 351–357. [Google Scholar]
  48. Carling, D. The AMP-activated protein kinase cascade—A unifying system for energy control. Trends Biochem. Sci. 2004, 29, 18–24. [Google Scholar] [CrossRef]
  49. Pankiv, S.; Clausen, T.H.; Lamark, T.; Brech, A.; Bruun, J.A.; Outzen, H.; Overvatn, A.; Bjorkoy, G.; Johansen, T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 2007, 282, 24131–24145. [Google Scholar] [CrossRef] [Green Version]
  50. Cadwell, K.; Philips, J.A. Autophagy meets phagocytosis. Immunity 2013, 39, 425–427. [Google Scholar] [CrossRef] [Green Version]
  51. Zhang, Z.Y.; Bao, X.L.; Cong, Y.Y.; Fan, B.; Li, G.Y. Autophagy in age-related macular degeneration: A regulatory mechanism of oxidative stress. Oxid. Med. Cell. Longev. 2020, 2020, 2896036. [Google Scholar] [CrossRef]
  52. Pakravan, K.; Babashah, S.; Sadeghizadeh, M.; Mowla, S.J.; Mossahebi-Mohammadi, M.; Ataei, F.; Dana, N.; Javan, M. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1alpha/VEGF signaling axis in breast cancer cells. Cell. Oncol. 2017, 40, 457–470. [Google Scholar] [CrossRef]
  53. Grundmann, S.; Hans, F.P.; Kinniry, S.; Heinke, J.; Helbing, T.; Bluhm, F.; Sluijter, J.P.; Hoefer, I.; Pasterkamp, G.; Bode, C.; et al. MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 2011, 123, 999–1009. [Google Scholar] [CrossRef] [Green Version]
  54. Kovacs, B.; Lumayag, S.; Cowan, C.; Xu, S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Investig. Ophthalmol. Vis. Sci. 2011, 52, 4402–4409. [Google Scholar] [CrossRef]
  55. Chang, Y.C.; Kao, Y.H.; Hu, D.N.; Tsai, L.Y.; Wu, W.C. All-trans retinoic acid remodels extracellular matrix and suppresses laminin-enhanced contractility of cultured human retinal pigment epithelial cells. Exp. Eye Res. 2009, 88, 900–909. [Google Scholar] [CrossRef]
  56. Wu, W.C.; Lai, Y.H.; Hsieh, M.C.; Chang, Y.C.; Wu, M.H.; Wu, H.J.; Chang, C.W.; Wu, K.Y.; Kao, Y.H. Pleiotropic role of atorvastatin in regulation of human retinal pigment epithelial cell behaviors in vitro. Exp. Eye Res. 2011, 93, 842–851. [Google Scholar] [CrossRef]
Pharmaceuticals 14 00314 g001 550
Figure 1. Hydrogen peroxide treatment induces miR-100 biosynthesis in human ARPE-19 cells. (A) ARPE-19 cells were treated with H2O2 at indicated doses for 24 h and subjected to cellular viability assay. (B,C) Alternatively, biosynthesis and release of miRNA was measured by isolating miRNA from lysates and conditioned media, followed by miRNA-100 quantification using RT-qPCR. All data are shown in mean ± SD from three independent experiments. * p < 0.05 vs. zero control by t-Test. MC, medium control; ND, not detectable.
Figure 1. Hydrogen peroxide treatment induces miR-100 biosynthesis in human ARPE-19 cells. (A) ARPE-19 cells were treated with H2O2 at indicated doses for 24 h and subjected to cellular viability assay. (B,C) Alternatively, biosynthesis and release of miRNA was measured by isolating miRNA from lysates and conditioned media, followed by miRNA-100 quantification using RT-qPCR. All data are shown in mean ± SD from three independent experiments. * p < 0.05 vs. zero control by t-Test. MC, medium control; ND, not detectable.
Pharmaceuticals 14 00314 g001
Pharmaceuticals 14 00314 g002 550
Figure 2. Characterization of hydrogen peroxide-driven signaling kinetics in human ARPE-19 cells. (A) ARPE-19 cells were treated with 225 μM of H2O2 for the indicated time. Cellular protein lysates were subjected to western blotting detection for total and phosphorylated kinase proteins. Densitometric analysis was used to quantify phosphorylation levels of Akt (B), ERK1/2 (C), JNK (D), p38 MAPK (E), and NF-κB (F). Data are expressed as mean values from three independent experiments.
Figure 2. Characterization of hydrogen peroxide-driven signaling kinetics in human ARPE-19 cells. (A) ARPE-19 cells were treated with 225 μM of H2O2 for the indicated time. Cellular protein lysates were subjected to western blotting detection for total and phosphorylated kinase proteins. Densitometric analysis was used to quantify phosphorylation levels of Akt (B), ERK1/2 (C), JNK (D), p38 MAPK (E), and NF-κB (F). Data are expressed as mean values from three independent experiments.
Pharmaceuticals 14 00314 g002
Pharmaceuticals 14 00314 g003 550
Figure 3. Involvement of hydrogen peroxide-activated signaling in induced miR-100 biosynthesis in human ARPE-19 cells. ARPE-19 cells were pretreated with kinase-specific inhibitors for 1 h, including the PI3K inhibitor LY294002 (LY, 10 µM), MEK1 inhibitor PD98059 (PD, 10 µM), p38 inhibitor SB203580 (SB, 20 µM), JNK inhibitor SP600125 (SP, 20 µM), NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC, 50 µM), or equivalent dimethyl sulfoxide (DMSO) as solvent control, followed by H2O2 exposure at 225 µM. After 24 h of treatment, lysates (A) and conditioned media (B) were subjected to miRNA isolation and subsequent RT-qPCR detection for miRNA-100 levels. Semi-quantitative mRNA levels are shown as an induction fold of negative control (NC) in mean ± SD from three independent experiments. * p < 0.05 vs. NC group; # p < 0.05 vs. DMSO groups by ANOVA.
Figure 3. Involvement of hydrogen peroxide-activated signaling in induced miR-100 biosynthesis in human ARPE-19 cells. ARPE-19 cells were pretreated with kinase-specific inhibitors for 1 h, including the PI3K inhibitor LY294002 (LY, 10 µM), MEK1 inhibitor PD98059 (PD, 10 µM), p38 inhibitor SB203580 (SB, 20 µM), JNK inhibitor SP600125 (SP, 20 µM), NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC, 50 µM), or equivalent dimethyl sulfoxide (DMSO) as solvent control, followed by H2O2 exposure at 225 µM. After 24 h of treatment, lysates (A) and conditioned media (B) were subjected to miRNA isolation and subsequent RT-qPCR detection for miRNA-100 levels. Semi-quantitative mRNA levels are shown as an induction fold of negative control (NC) in mean ± SD from three independent experiments. * p < 0.05 vs. NC group; # p < 0.05 vs. DMSO groups by ANOVA.
Pharmaceuticals 14 00314 g003
Pharmaceuticals 14 00314 g004 550
Figure 4. Involvement of hydrogen peroxide-activated signaling in its cytotoxic effect on human ARPE-19 cells. ARPE-19 cells were pretreated with kinase-specific inhibitors for 1 h, including the PI3K inhibitor LY294002 (LY, 10 µM), MEK1 inhibitor PD98059 (PD, 10 µM), p38 inhibitor SB203580 (SB, 20 µM), JNK inhibitor SP600125 (SP, 20 µM), NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC, 50 µM), or equivalent dimethyl sulfoxide (DMSO) as solvent control, followed by transient H2O2 exposure at 225 µM for 2 h. After another 22-h incubation, the treated cells were subjected to cytotoxicity assay. Cell viability is expressed as a percentage of negative control (NC) in mean ± SD from three independent experiments. * p < 0.05 vs. NC group; # p < 0.05 vs. DMSO groups by ANOVA.
Figure 4. Involvement of hydrogen peroxide-activated signaling in its cytotoxic effect on human ARPE-19 cells. ARPE-19 cells were pretreated with kinase-specific inhibitors for 1 h, including the PI3K inhibitor LY294002 (LY, 10 µM), MEK1 inhibitor PD98059 (PD, 10 µM), p38 inhibitor SB203580 (SB, 20 µM), JNK inhibitor SP600125 (SP, 20 µM), NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC, 50 µM), or equivalent dimethyl sulfoxide (DMSO) as solvent control, followed by transient H2O2 exposure at 225 µM for 2 h. After another 22-h incubation, the treated cells were subjected to cytotoxicity assay. Cell viability is expressed as a percentage of negative control (NC) in mean ± SD from three independent experiments. * p < 0.05 vs. NC group; # p < 0.05 vs. DMSO groups by ANOVA.
Pharmaceuticals 14 00314 g004
Pharmaceuticals 14 00314 g005 550
Figure 5. Mitigation of hydrogen peroxide-induced apoptosis of human ARPE-19 cells by miR-100 antagonism. ARPE-19 cells were transfected with either a 200 nM miR-100 antagonist or control oligonucleotides for 24 h followed by H2O2 exposure at 225 µM for another 24 h. (A) Cellular lysates and conditioned media were collected for miRNA isolation and miR-100 detection by RT-qPCR. ND, not detectable. (B) Cytotoxicity assay was used to determine the viability of the treated cells. Alternatively, the treated cells were fixed and subjected to fluorescent TUNEL staining (C) and subsequent analysis on TUNEL staining positivity (D). Data are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. control or between indicated groups, by ANOVA. Scale bar = 50 µm. +/− indicates presence/absence of reagents.
Figure 5. Mitigation of hydrogen peroxide-induced apoptosis of human ARPE-19 cells by miR-100 antagonism. ARPE-19 cells were transfected with either a 200 nM miR-100 antagonist or control oligonucleotides for 24 h followed by H2O2 exposure at 225 µM for another 24 h. (A) Cellular lysates and conditioned media were collected for miRNA isolation and miR-100 detection by RT-qPCR. ND, not detectable. (B) Cytotoxicity assay was used to determine the viability of the treated cells. Alternatively, the treated cells were fixed and subjected to fluorescent TUNEL staining (C) and subsequent analysis on TUNEL staining positivity (D). Data are expressed as mean ± SD from three independent experiments. * p < 0.05 vs. control or between indicated groups, by ANOVA. Scale bar = 50 µm. +/− indicates presence/absence of reagents.
Pharmaceuticals 14 00314 g005
Pharmaceuticals 14 00314 g006 550
Figure 6. Effects of miR-100 inhibition on AMPK/mTOR signaling and heme oxygenase 1 (HO-1) expression in human ARPE-19 cells. ARPE-19 cells were transfected with either an miR-100 inhibitor or negative miRNA control nucleotides for 24 h followed by H2O2 exposure at 225 μM for another 24 h. After treatments, cellular protein lysates were collected for western blotting detection (A) and subsequent densitometry analysis for p-AMPK (B), total mTOR (C), HO-1 (D), and p62 levels (E). Data are expressed as mean ± SD from three independent experiments. * p < 0.05 between indicated groups by ANOVA. +/− indicates presence/absence of reagents.
Figure 6. Effects of miR-100 inhibition on AMPK/mTOR signaling and heme oxygenase 1 (HO-1) expression in human ARPE-19 cells. ARPE-19 cells were transfected with either an miR-100 inhibitor or negative miRNA control nucleotides for 24 h followed by H2O2 exposure at 225 μM for another 24 h. After treatments, cellular protein lysates were collected for western blotting detection (A) and subsequent densitometry analysis for p-AMPK (B), total mTOR (C), HO-1 (D), and p62 levels (E). Data are expressed as mean ± SD from three independent experiments. * p < 0.05 between indicated groups by ANOVA. +/− indicates presence/absence of reagents.
Pharmaceuticals 14 00314 g006
Pharmaceuticals 14 00314 g007 550
Figure 7. Effects of miR-100 inhibition on cellular expression and distribution of p62 in human ARPE-19 cells under oxidative stress. ARPE-19 cells were transfected with either miR-100 inhibitor or miRNA control nucleotides for 24 h followed by H2O2 exposure at 225 μM for another 24 h. Afterward, the cells were fixed and subjected to immunofluorescent staining. Note that miR-100 inhibition restored autophagy-associated perinuclear granules in the H2O2-exposed cells. Scale bar = 20 μm.
Figure 7. Effects of miR-100 inhibition on cellular expression and distribution of p62 in human ARPE-19 cells under oxidative stress. ARPE-19 cells were transfected with either miR-100 inhibitor or miRNA control nucleotides for 24 h followed by H2O2 exposure at 225 μM for another 24 h. Afterward, the cells were fixed and subjected to immunofluorescent staining. Note that miR-100 inhibition restored autophagy-associated perinuclear granules in the H2O2-exposed cells. Scale bar = 20 μm.
Pharmaceuticals 14 00314 g007
Pharmaceuticals 14 00314 g008 550
Figure 8. A hypothetical scheme showing the network of oxidative-stress-induced signal pathways, miR-100 biosynthesis, and their roles in the oxidative cell death of retinal pigment epithelial (RPE) cells. The study findings demonstrated that hydrogen peroxide (H2O2)-mimicked oxidative stress may activate signaling pathways including the hyperphosphorylation of Akt, JNK, p38 MAPK, ERK, and NF-κB. The mediator activities of PI3K/Akt, p38 MAPK, and NF-κB contribute to endogenous miR-100 expression, thereby leading to apoptotic cell death. The NF-κB signal mediator very likely lies downstream of the Akt and JNK axes, which awaits further elucidation. The PI3K/Akt/mTOR axis is known to mediate cell survival signals. Mechanistically, miR-100 antagomir treatment not only attenuates oxidative stress-related AMPK phosphorylation but also restores cellular mTOR and p62 levels and upregulates antioxidant heme oxygenase-1 (HO-1) expression, thereby protecting RPE cells against oxidative cell death. Arrows, stimulatory; T lines, inhibitory; Solid lines, new findings of this study; Dashed line, previously identified mechanism; Question marks, unknown mechanisms.
Figure 8. A hypothetical scheme showing the network of oxidative-stress-induced signal pathways, miR-100 biosynthesis, and their roles in the oxidative cell death of retinal pigment epithelial (RPE) cells. The study findings demonstrated that hydrogen peroxide (H2O2)-mimicked oxidative stress may activate signaling pathways including the hyperphosphorylation of Akt, JNK, p38 MAPK, ERK, and NF-κB. The mediator activities of PI3K/Akt, p38 MAPK, and NF-κB contribute to endogenous miR-100 expression, thereby leading to apoptotic cell death. The NF-κB signal mediator very likely lies downstream of the Akt and JNK axes, which awaits further elucidation. The PI3K/Akt/mTOR axis is known to mediate cell survival signals. Mechanistically, miR-100 antagomir treatment not only attenuates oxidative stress-related AMPK phosphorylation but also restores cellular mTOR and p62 levels and upregulates antioxidant heme oxygenase-1 (HO-1) expression, thereby protecting RPE cells against oxidative cell death. Arrows, stimulatory; T lines, inhibitory; Solid lines, new findings of this study; Dashed line, previously identified mechanism; Question marks, unknown mechanisms.
Pharmaceuticals 14 00314 g008
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chang, Y.-S.; Chang, Y.-C.; Chen, P.-H.; Li, C.-Y.; Wu, W.-C.; Kao, Y.-H. MicroRNA-100 Mediates Hydrogen Peroxide-Induced Apoptosis of Human Retinal Pigment Epithelium ARPE-19 Cells. Pharmaceuticals 2021, 14, 314. https://doi.org/10.3390/ph14040314

AMA Style

Chang Y-S, Chang Y-C, Chen P-H, Li C-Y, Wu W-C, Kao Y-H. MicroRNA-100 Mediates Hydrogen Peroxide-Induced Apoptosis of Human Retinal Pigment Epithelium ARPE-19 Cells. Pharmaceuticals. 2021; 14(4):314. https://doi.org/10.3390/ph14040314

Chicago/Turabian Style

Chang, Yuh-Shin, Yo-Chen Chang, Po-Han Chen, Chia-Yang Li, Wen-Chuan Wu, and Ying-Hsien Kao. 2021. "MicroRNA-100 Mediates Hydrogen Peroxide-Induced Apoptosis of Human Retinal Pigment Epithelium ARPE-19 Cells" Pharmaceuticals 14, no. 4: 314. https://doi.org/10.3390/ph14040314

APA Style

Chang, Y.-S., Chang, Y.-C., Chen, P.-H., Li, C.-Y., Wu, W.-C., & Kao, Y.-H. (2021). MicroRNA-100 Mediates Hydrogen Peroxide-Induced Apoptosis of Human Retinal Pigment Epithelium ARPE-19 Cells. Pharmaceuticals, 14(4), 314. https://doi.org/10.3390/ph14040314

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop